Trials / Completed
CompletedNCT03466814
Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin
ORENCIA Safety Surveillance in Japanese Children and Adolescents With Active Juvenile Idiopathic Arthritis (JIA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Observational study of abatacept in the treatment of JIA in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non-Interventional |
Timeline
- Start date
- 2018-04-06
- Primary completion
- 2021-07-21
- Completion
- 2021-07-21
- First posted
- 2018-03-15
- Last updated
- 2022-06-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03466814. Inclusion in this directory is not an endorsement.